Analyst: Apple Watch Could Boost This Stock

Apple Watch's new heart-monitoring capabilities could be a boon for iRhythm's Zio device

by Andrea Kramer

Published on Sep 13, 2018 at 2:05 PM

The shares of digital healthcare company iRhythm Technologies Inc (NASDAQ:IRTC) are higher in afternoon trading, courtesy of an optimistic analyst note. Specifically, Canaccord said Apple's (AAPL) newly unveiled Apple Watch, which now features heart-monitoring capabilities, could popularize prophylactic monitoring -- and be a boon for iRhythm's Zio heart rate detector. Against this backdrop, the analysts upped their price target on IRTC stock to $100 from $93, and the shares are flirting with all-time highs as a result.

iRhythm stock was last seen 6.8% higher at $95.65, and earlier touched a record high of $98.37. The security has now more than doubled since its Nov. 9 low of $46.95, and is on pace for its best day since Aug. 2.

IRTC stock chart

Additional price-target hikes could be on the horizon for IRTC, too. Currently, the consensus 12-month price target stands at $93, representing a discount to current trading levels. Should more analysts lift their targets, additional buyers could flock to the shares.

Plus, a continued short squeeze could add fuel to iRhythm's fire. Short interest fell 21.1% in the past two reporting periods, but still represents a healthy 7% of IRTC's total available float. At the stock's average pace of trading, it would take about seven sessions to buy back these remaining bearish bets.

a schaeffer's exclusive


We're celebrating 38 years with this FREE insider report!



NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

What's Next for the American Wealth Gap
Porter Stansberry is predicting a major change in the American economic system.
Huawei Warning Smacks Cree Below Key Trendline
The LED specialist forecast a current-quarter loss on Huawei headwinds
INmune Bio Stock Gains on New "Buy" Rating
The shares hit a record low just last week
IRA/401K Investment Guide: 2019 Stock Market Crash
Use gold to protect any IRA, 401(k), or retirement account from a looming financial crisis.